Email updates

Keep up to date with the latest news and content from BMC Hematology and BioMed Central.

Open Access Case report

Extensive myocardial infiltration by hemopoietic precursors in a patient with myelodysplastic syndrome

Farrah J Mateen1, Sheila R Harding23 and Anurag Saxena2*

Author Affiliations

1 Department of Neurology, Mayo Clinic1, Rochester, USA

2 Departments of Pathology and Internal Medicine, University of Saskatchewan and Saskatoon Health Region, Saskatoon, Canada

3 Department of Pathology, University of Saskatchewan and Saskatoon Health Region, Saskatoon, Canada

For all author emails, please log on.

BMC Blood Disorders 2006, 6:4  doi:10.1186/1471-2326-6-4

Published: 5 September 2006

Abstract

Background

Although myocardial infiltration with leukemic blasts is a known finding in patients with acute leukemia, this phenomenon in myelodysplasia is not reported in the literature. Cardiac symptoms in patients with myelodysplasia are often due to anemia and may be due to iron overload and side effects of therapy.

Case presentation

Herein we report the first case of neoplastic infiltration of the heart with associated myocardial necrosis in a patient with myelodysplasia. It was associated with unicellular and multifocal geographic areas of necrosis in the left ventricle and the interventricular septum. It is likely that cardiac compromise in our patient was due to a combination of restrictive cardiomyopathy due to leukemic infiltration, concomitant anemia, cardiac dilatation, conduction blocks and myocardial necrosis. Myocardial necrosis was most likely due to a combination of ischemic damage secondary to anemia and prolonged hypotension and extensive leukemic infiltration. Markedly rapid decrease in ejection fraction from 66% to 33% also suggests the role of ischemia, since leukemic infiltration is not expected to cause this degree of systolic dysfunction over a 24-hour period. The diagnosis was not suspected during life due to concomitant signs and symptoms of anemia, pulmonary infections, and pericardial and pleural effusions. The patient succumbed to cardiac failure.

Conclusion

Hemopoietic cell infiltration was not considered in the differential diagnosis and contributed to this patient's morbidity and mortality. This case highlights the clinical importance of considering myocardial infiltration in patients with myelodysplasia and cardiac symptoms.